Cappasity Starts ARToken crowdsale and Adds Cryptocurrency Expert David Drake to its Advisory Board
SANTA CLARA, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Cappasity, a company that develops a platform and an AR/VR blockchain ecosystem for 3D content production and mass distribution, is announcing the start of a crowdsale of ARToken (AR) on October 25, at 1 PM UTC. David Drake, Chairman at LDJ Capital, joins Cappasity's advisory board to provide counsel on critical issues relating to the specifics of the ICO process, blockchain and investor relations.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/aaaee806-98e3-476f-90ce-eb06e91d7e43
Today, Cappasity is announcing the start of the crowdsale of ARToken - a new digital currency that will be used as the primary payment unit within the global decentralized AR/VR Ecosystem for 3D content exchange.
As a token sale is a very important step for the development of the company's project, Cappasity has decided to consult the deep expertise of one of the leading specialists in blockchain, cryptocurrency and international business development - David Drake, Chairman at LDJ Capital. David has shown his strong interest in the project and joined Cappasity's advisory board.
David Drake is the Chairman of LDJ Capital, a family office; Victoria Partners, LDJ Real Estate Group; Drake Hospitality Group; and, The Soho Loft Media Group. LDJ Capital's extended network of funds of funds and hedge funds manages 1.5 trillion USD in assets. Mr. Drake's access to 100,000 investors is maintained through his media holding investment, The Soho Loft Media Group which has produced and sponsored over 1500+ global finance conferences since 2002. David is actively involved in the Crypto community as a speaker and has helped ICO firms he advised raise in excess of $100M in funding.
"AR/VR market is rapidly growing, with diverse content being the driving force behind the industry's growth. I found the project by Cappasity having every chance to come off since Cappasity creates a convenient environment where high-quality 3D content will be produced in large amounts. I am really glad to share my expertise with Cappasity to help bring future changes into the industry," said David Drake, Partner at LDJ Capital.
"3D content is becoming a critical component in multiple verticals including gaming, entertainment, retail, art, education, and health. Cappasity will leverage the blockchain to become the global 3D/AR/VR content exchange ecosystem for the users, developers and businesses who will benefit from 3D image creation, embedding and trading," noted Kosta Popov, Cappasity founder and CEO. "We are excited to bring innovative content creators the opportunity to participate in the AR/VR content revolution with the utility ARToken (ART) to power the whole ecosystem."
The ARToken crowdsale begins on the 25th of October and will last for 4 weeks. Cappasity platform, a beta-version of which was released in January 2017, plans to attract a total of $30m within Phase 1. The latter is divided into three tiers. Tier 1 allows participants to get up to a 20% bonus. Total investment in the company from VC funds and angel investors so far amounted to $1.8m.
Website - https://www.artoken.io
Twitter - https://twitter.com/cappasity
Facebook - https://www.facebook.com/cappasity
Telegram - https://t.me/artoken
Linkedin - https://www.linkedin.com/company/cappasity-inc-
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cappasity Inc. via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer20.11.2017 13:00 | Pressemelding
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status Approval supported by robust data from a randomized, well-controlled Phase 3 trial Only PARPi to offer once-daily, oral dosing to enable convenient administration for maintenance treatment First commercial launches planned for Germany and the UK this December ZUG, Switzerland, Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that the European Commission (EC) has granted marketing authorization for ZEJULA® (niraparib) as a monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete response (CR) or partial response (PR) to platinum-based chemotherapy. ZEJULA is the first once-daily, oral poly (
PledPharma and Solasia enter license agreement to develop and commercialize PledOx® in Asia20.11.2017 07:30 | Pressemelding
Stockholm, 2017-11-20 07:30 CET (GLOBE NEWSWIRE) -- Stockholm, Sweden / Tokyo, Japan, November 20th 2017 - PledPharma AB (“PledPharma”) (STO: PLED) and Solasia Pharma K.K. (“Solasia”) (TSE: 4597) today jointly announce that they have entered a license agreement pertaining to the clinical development and commercialization of PledOx® in Japan, China, Hong Kong, Macau, South Korea and Taiwan. Under the terms of this agreement, PledPharma grants exclusive development and commercialization rights to PledOx® in the territories mentioned and Solasia will pay upfront, development, regulatory and sales milestones of up to ~USD 83 million (SEK 700 million)*. In addition, Solasia will pay industry standard royalty rates on sales applicable for a deal pertaining to an in-licensed asset in Phase III development. Solasia will also fully finance an expansion of the Phase III program to include Asian patients subject to regulatory consultations. The license agreement is initially focused on th
CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research17.11.2017 18:07 | Pressemelding
SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scientific advancement of Patient Derived Xenograft (PDX) technology. Research Grants up to $50,000 will be awarded to projects focused on accelerating the pace of preclinical innovation and novel PDX methodologies that improve clinical predictions with sound science. The program offers an opportunity for investigators to receive funding for projects that may not receive support through traditional funding channels. Submitted proposals will be reviewed and selected by CrownBio's Scientific Steering Committee with the goa
Barings Backs Sentinel Capital Partners in Acquisition of Nekoosa17.11.2017 17:00 | Pressemelding
CHARLOTTE, N.C., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as Lead Agent on a senior secured credit facility to support Sentinel Capital Partners in its acquisition of Nekoosa ("Nekoosa" or the "Company"). Headquartered in Nekoosa, Wisconsin, the Company is a leading manufacturer of specialty paper and film products used in the graphics and commercial print markets, including application and pressure-sensitive tapes, specialty synthetic papers, sheeted digital and offset grade carbonless paper, and extruded film products. Nekoosa serves a highly diverse base of more than 70,000 commercial print and graphics shops in 65 countries. Barings served as lead senior lender on the transaction, which included a senior term loan and a revolving credit facility. "Sentinel is pleased to have Barings' support on our investment in Nekoosa," said Scott Perry, a partner with Sentinel Capital Partner
At SC17, ExaScaler and PEZY Computing Unveil Gyoukou Supercomputer with a High Combined Green500/Top500 Ranking16.11.2017 23:29 | Pressemelding
ExaScaler and PEZY Computing Also Take Top Three Green500 Positions DENVER, Nov. 16, 2017 (GLOBE NEWSWIRE) -- At SC17, ExaScaler and PEZY Computing unveiled their Gyoukou supercomputer whose Green500 and Top500 rankings attest to a unique combination of high efficiency and computing power. The Gyoukou supercomputer is installed at the Yokohama Research Institute in Japan. (Video: PEZY Liquid immersion cooling) PEZY supercomputers leverage 48V Factorized Power, a high efficiency, high density power distribution architecture. PEZY's CPUs are co-packaged with Vicor's Power-on-Package ("PoP") Modular Current Multipliers ("MCMs"), which enable efficient, direct 48V to sub-1V current multiplication at the XPU. ExaScaler and PEZY Computing also achieved the #1, #2 and #3 positions on the Green500. These supercomputer system installations also utilize 48V Factorized Power. Come see us at SC17 at Booth 633 where ExaScaler / PEZY Computing will be
ELS Educational Services, Inc. Launches New Vacation English Program Starting January 201816.11.2017 20:59 | Pressemelding
New York, New York, Nov. 16, 2017 (GLOBE NEWSWIRE) -- ELS Educational Services, Inc. - one of the leading language services providers worldwide - has launched a new vacation English language program, ELS Language Experience+, which is set to begin enrollment for January 2018. "Here at ELS, our students and their English language goals always come first, and we are proud to introduce ELS Language Experience+ as an exciting new addition to the many quality programs we offer them," said ELS Chief Operating Officer, Reiji Terasaka. "This conversation-oriented, flexible new vacation English program allows students to make the most of their English instruction while gaining an invaluable cultural experience at the same time." ELS Language Experience+ concentrates on everyday speaking, communication skills and discussion, within a flexible course structure (three or six hours of study per day). Courses offered include: Everyday English, Grammar in Action, D
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom